BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8029884)

  • 1. Mechanism of tolerance in mixed xenogeneic chimeras prepared with a nonmyeloablative conditioning regimen.
    Lee LA; Sergio JJ; Sachs DH; Sykes M
    Transplant Proc; 1994 Jun; 26(3):1197-8. PubMed ID: 8029884
    [No Abstract]   [Full Text] [Related]  

  • 2. Humoral tolerance in mixed xenogeneic chimeras prepared by a nonmyeloablative conditioning regimen.
    Aksentijevich I; Sharabi Y; Sundt TM; Sachs DH; Sykes M
    Transplant Proc; 1991 Feb; 23(1 Pt 1):880-2. PubMed ID: 1990712
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism.
    Ito H; Takeuchi Y; Shaffer J; Sykes M
    Transplantation; 2006 Jul; 82(2):251-7. PubMed ID: 16858289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-species transplantation tolerance: rat bone marrow-derived cells can contribute to the ligand for negative selection of mouse T cell receptor V beta in chimeras tolerant to xenogeneic antigens (mouse + rat----mouse).
    Ildstad ST; Vacchio MS; Markus PM; Hronakes ML; Wren SM; Hodes RJ
    J Exp Med; 1992 Jan; 175(1):147-55. PubMed ID: 1530958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed xenogeneic chimerism (mouse+rat-->mouse) to induce donor-specific tolerance to sequential or simultaneous islet xenografts.
    Li H; Ricordi C; Demetris AJ; Kaufman CL; Korbanic C; Hronakes ML; Ildstad ST
    Transplantation; 1994 Feb; 57(4):592-8. PubMed ID: 8116047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in tolerization of T-independent and T-dependent xenoantibody formation after cardiac xenotransplantation in rats.
    Lin Y; Vandeputte M; Waer M
    Transplant Proc; 1996 Apr; 28(2):741. PubMed ID: 8623376
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for thymic maturation of both rat and mouse T cells in mixed xenogeneic chimeras (B10 mouse+F344 rat----B10 mouse).
    Abou el-Ezz AY; Schuchert MJ; Wren SM; Hronakes ML; Beck TP; Ildstad ST
    Transplant Proc; 1992 Apr; 24(2):501-2. PubMed ID: 1348886
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of natural antibody on xenogeneic bone marrow engraftment.
    Sykes M; Sachs DH; Aksentijevich I
    Transplant Proc; 1992 Apr; 24(2):497-8. PubMed ID: 1566403
    [No Abstract]   [Full Text] [Related]  

  • 10. In utero transplantation of rat hematopoietic stem cells induces xenogeneic chimerism in mice.
    Rice HE; Hedrick MH; Flake AW
    Transplant Proc; 1994 Feb; 26(1):126-8. PubMed ID: 7906444
    [No Abstract]   [Full Text] [Related]  

  • 11. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xenoreactivity in mouse + rat-->mouse chimeras.
    Conrad BG; Wren SM; Thai NL; Wang SC; Ricordi C; Fung JJ; Perry FE; Ildstad ST
    Transplant Proc; 1993 Feb; 25(1 Pt 1):455-6. PubMed ID: 8438377
    [No Abstract]   [Full Text] [Related]  

  • 13. Impaired B-cell tolerance in complete as compared with mixed chimeras after allogeneic bone marrow transplantation.
    Waer M; Salam A; Vandeputte M
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1281-2. PubMed ID: 8442112
    [No Abstract]   [Full Text] [Related]  

  • 14. Application of chimerism-based drug-induced tolerance to rat into mouse xenotransplantation.
    Tomita Y; Shimizu I; Iwai T; Zhang QW; Okano S; Kajiwara T; Onzuka T; Tominaga R
    Scand J Immunol; 2006 Oct; 64(4):392-7. PubMed ID: 16970680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
    Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-species mixed chimerism (mouse + rat----mouse): facilitated engraftment of rat stem cells with untreated rat bone marrow.
    van den Brink MR; Wren SM; French SW; Hronakes ML; Ildstad ST
    Transplant Proc; 1991 Feb; 23(1 Pt 1):807-8. PubMed ID: 1671307
    [No Abstract]   [Full Text] [Related]  

  • 17. Xenotransplantation from pig to cynomolgus monkey: approach toward tolerance induction.
    Latinne D; Gianello P; Smith CV; Nickeleit V; Kawai T; Beadle M; Haug C; Sykes M; Lebowitz E; Bazin H
    Transplant Proc; 1993 Feb; 25(1 Pt 1):336-8. PubMed ID: 8438325
    [No Abstract]   [Full Text] [Related]  

  • 18. Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model.
    Ploemacher RE; Johnson KW; Rombouts EJ; Etienne K; Westerhof GR; Baumgart J; White-Scharf ME; Down JD
    Biol Blood Marrow Transplant; 2004 Apr; 10(4):236-45. PubMed ID: 15077222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat peripheral T-cell receptor V beta repertoire in F344-to-B10 (rat-to-mouse) mixed xenogeneic chimeras.
    Huang Y; Neipp M; Ildstad ST; Shirwan H
    Transplant Proc; 1999; 31(1-2):978-9. PubMed ID: 10083435
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.
    Masaki H; Appel MC; Leahy L; Leif J; Paquin L; Shultz LD; Mordes JP; Greiner DL; Rossini AA
    Xenotransplantation; 2006 May; 13(3):224-32. PubMed ID: 16756565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.